The Southern California Regional Gamma Knife Center (Tables)

6 Months Ended

Jun. 30, 2023

Neuro Partners LLC and CGK [Member]

Schedule of Equity Method Investments [Line Items]

Equity Method Investment Summarized Financial Information

The following tables present the aggregation of summarized financial information of NeuroPartners LLC and CGK:

NeuroPartners LLC and CGK Condensed Combined Income Statement Information

	Six Months Ended
	June 30,
	2023			2022
Patient revenue	$	136,000		$	170,000
Net loss	$	(75,000	)	$	8,000
USNC’s equity in (loss) earnings of NeuroPartners LLC and CGK	$	(63,000	)	$	(5,000	)

	Three Months Ended
	June 30,
	2023			2022
Patient Revenue	$	40,000		$	277,000
Net loss	$	(38,000	)	$	(27,000	)
USNC’s equity in earnings of NeuroPartners, LLC and CGK	$	(37,000	)	$	(28,000	)

NeuroPartners LLC and CGK Condensed Combined Balance Sheet Information

	June 30,			December 31,
	2023			2022
Current assets	$	363,000		$	375,000
Noncurrent assets		-			42,000
Total assets	$	363,000		$	417,000
Current liabilities	$	653,000		$	632,000
Noncurrent liabilities		-			-
Equity		(290,000	)		(215,000	)
Total liabilities and equity	$	363,000		$	417,000